• Back

    Stilla Technologies completes a €16 Million funding round to commercialise its novel digital PCR system

    Posté le : 11/20/2018

    Stilla Technologies, the European provider of pioneering digital PCR solutions for high precision genetic analysis, announced today the successful completion of a Series A financing round of 16 million euros ($18 Million) led by Illumina Ventures with participation from  Idinvest Partners. 

    Since 2016, Stilla Technologies has been providing research organisations specialised in molecular biology and genetic analysis with its Naica System, a ground-breaking digital PCR solution that enables scientists to detect and quantify DNA mutations with unrivalled precision.